J. García-Mata

发表

Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials.

A. Lluch, I. Tusquets, Á. Rodríguez-Lescure, 2007, Cancer treatment reviews.

Electronic health records and patient registries in medical oncology departments in Spain

N. Ribelles, C. Jara, J. Chacón, 2021, Clinical and Translational Oncology.

Functions and workload of medical oncologists in Spain

J. Albanell, E. Alba, Á. Rodríguez-Lescure, 2012, Clinical and Translational Oncology.

Pilot study on workload estimate in breast cancer, lung cancer and colorectal cancer in a Medical Oncology Service at Valme hospital

J. Albanell, E. Alba, Á. Rodríguez-Lescure, 2012, Clinical and Translational Oncology.

Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report

I. Abdulkader, C. Rolfo, C. Labandeira, 2019, Front. Oncol..

Primary malignant melanoma of the biliary tract: A case report and literature review

J. García-Mata, Soledad Cameselle-García, José L. Pérez, 2019, World journal of clinical cases.

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.

A. Ruíz, V. Guillem, N. Ribelles, 2007, The Lancet. Oncology.

Dynamic Modeling of Silicon Bioavailability, Uptake, Transport, and Accumulation: Applicability in Improving the Nutritional Quality of Tomato

M. López-Pérez, S. González-Morales, A. Juárez-Maldonado, 2018, Front. Plant Sci..

Dolor neuropático y quistes de Tarlov

J. García-Mata, N. Lara-Sires, Salvador Alegre-Herrera, 2006 .

[Neuropathic pain and Tarlov cyst].

J. García-Mata, N. Lara-Sires, Salvador Alegre-Herrera, 2006, Medicina clinica.

Supportive care for patients with early breast cancer

A. Lluch, I. Tusquets, I. Álvarez, 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Current controversies in the management of early breast cancer

J. Albanell, A. Lluch, I. Tusquets, 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study

J. Feliu, M. Salgado, E. Casado, 2009, Cancer Chemotherapy and Pharmacology.

Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings.

R. González-Sarmiento, A. Dueñas-González, J. García-Mata, 1996, Cancer letters.

Novel therapeutic approaches to the treatment of metastatic breast cancer.

J. Cueva, A. de Juan, M. Ramos, 2010, Cancer treatment reviews.

SEOM guideline for the treatment of malignant glioma

C. Balañà, O. Gallego, M. Gil, 2012, Clinical and Translational Oncology.

Breast cancer management in the elderly

J. Cueva, L. Calvo, S. Antolín, 2014, Clinical and Translational Oncology.

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study

M. Ramos, L. Calvo, A. González, 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

The use of taxanes in the neoadjuvant treatment of breast cancer: a review of randomized phase II/III trials.

J. Albanell, A. Lluch, I. Tusquets, 2007, Clinical breast cancer.

Ki-67 is a prognostic marker for hormone receptor positive tumors

T. García-Caballero, J. García-Mata, J. García-Gómez, 2016, Clinical and Translational Oncology.

Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists

J. Albanell, A. Lluch, A. de Juan, 2019, Journal of drug assessment.

Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer

M. Ramos, L. Calvo, J. García-Mata, 2008 .

P3-14-15: Non-Randomized, Open Label Phase II Trial Evaluating the Safety and Efficacy of Taxotere (T) Followed by Myocet (M) + Cyclophosphamide (C) as First-Line Treatment for HER2−Negative Breast Cancer (BC).

M. Ramos, L. Calvo, R. López, 2011 .

Phase III study of gemcitabine plus vinorelbine (VG) versus vinorelbine (V) in patients (pts) with metastatic breast cancer (MBC) previously treated with anthracyclines (A) and taxanes (T). Final results of GEICAM 2000-04 study.

E. Alba, L. Calvo, M. Muñoz, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.